LivaNova (LIVN) Cash & Equivalents (QoQ) (2015 - 2026)
LivaNova (LIVN) Cash & Equivalents (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.74 Bn | 194.14 Bn | 7.27 Bn |
| 2 | Stryker | 129.74 Bn | 126.26 Bn | 4.50 Bn |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.98 Bn | 73.44 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.19 Bn | 1.35 Bn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.12 Bn | 32.01 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn |
| 9 | Steris | 23.26 Bn | 22.77 Bn | 684.20 Mn |
| 10 | LivaNova | 4.32 Bn | 3.80 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.28% |
| Mar 31, 2026 | -15.08% |
| Mar 31, 2025 | 72.19% |
| Dec 31, 2024 | 23.82% |
| Sep 30, 2024 | 13.98% |
| Jun 30, 2024 | -0.85% |
| Mar 31, 2024 | -1.56% |
| Dec 31, 2023 | 4.21% |
| Sep 30, 2023 | -4.05% |
| Jun 30, 2023 | 0.92% |
| Mar 31, 2023 | 2.37% |
| Dec 31, 2022 | 9.54% |
| Sep 30, 2022 | -7.57% |
| Jun 30, 2022 | -5.06% |
| Sep 30, 2021 | -44.79% |
| Jun 30, 2021 | 30.43% |
| Mar 31, 2021 | -0.12% |
| Dec 31, 2020 | 10.98% |
| Sep 30, 2020 | -2.04% |
| Jun 30, 2020 | 84.82% |